0001437749-21-017256.txt : 20210721 0001437749-21-017256.hdr.sgml : 20210721 20210721083042 ACCESSION NUMBER: 0001437749-21-017256 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210709 FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lehoux Lawrence CENTRAL INDEX KEY: 0001873952 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 211102824 MAIL ADDRESS: STREET 1: 11879 SOLOMAN ST CITY: WINDSOR STATE: A6 ZIP: N8P 1P1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 3 1 rdgdoc.xml FORM 3 X0206 3 2021-07-09 0 0001653821 CEN BIOTECH INC CENBF 0001873952 Lehoux Lawrence 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Technology Officer Common Stock 3030000 D Lawrence Lehoux (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on July 9, 2021 and owned 3,030,000 shares of the Issuer's common stock at such date. /s/ Lawrence Lehoux 2021-07-21